文| Tom Marsilje
翻译| 刘宏 蒋松春 贺晓晖 范艺 黄志红
Tom博客地址| http://adventuresinlivingterminallyoptimistic.com/
Dung Le et al. ASCO-2015. Used with permission for non-profit, non-promotional educational purposes. 美国临床肿瘤学会2015年会版权许可.
(注:本图叫Kaplan Meier存活曲线图,绿线代表的MSI阳性病人在PD1抑制剂治疗下存活时间明显增加。)
http://blog.dana-farber.org/insight/2015/05/the-science-of-pd-1-and-immunotherapy/
http://fightcolorectalcancer.org/research-treatment/currently-incurable-scientist/releasing-the-pd-1-brakes-in-msi-high-crc-patients
http://www.henryford.com/body.cfm?id=48420
http://www.ncbi.nlm.nih.gov/pubmed/24780173
https://en.wikipedia.org/wiki/Cancer_biomarkers#Prognosis_and_treatment_predictions
http://blog.dana-farber.org/insight/2015/05/the-science-of-pd-1-and-immunotherapy/
https://en.wikipedia.org/wiki/Pembrolizumab
http://meetinglibrary.asco.org/content/143531-156
http://www.nejm.org/doi/full/10.1056/NEJMoa1500596
http://www.gastro.org/press_releases/2015/9/9/aga-recommends-all-patients-with-colorectal-cancer-get-tested-for-lynch-syndrome
http://www.henryford.com/body.cfm?id=48420
http://ghr.nlm.nih.gov/condition/lynch-syndrome
http://www.cancerresearch.org/cancer-immunotherapy/clinical-trial-finder
https://en.wikipedia.org/wiki/CAPOX
http://www.mdanderson.org/
https://en.wikipedia.org/wiki/Nivolumab
http://www.onclive.com/publications/contemporary-oncology/2014/February-2014/Immune-Checkpoint-Blockade-in-Cancer-Inhibiting-CTLA-4-and-PD-1PD-L1-With-Monoclonal-Antibodies
https://en.wikipedia.org/wiki/FOLFIRI
https://en.wikipedia.org/wiki/Bevacizumab
https://en.wikipedia.org/wiki/FOLFOX
https://en.wikipedia.org/wiki/Atezolizumab
联系客服